Overcoming original (antigenic) sin

被引:16
作者
Anderson, DE [1 ]
Carlos, MP [1 ]
Nguyen, L [1 ]
Torres, JV [1 ]
机构
[1] Univ Calif Davis, Sch Med Med Microbiol& Immunol, Davis, CA 95616 USA
关键词
HIV; AIDS; vaccine; peptide; T cell; memory;
D O I
10.1006/clim.2001.5114
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Original antigenic sin describes a phenomenon in which the antibody response elicited in an individual after a secondary viral infection reacts more strongly to the viral variant that originally infected the individual. As T helper cells play critical roles in promoting antibody responses, a similar phenomenon may hold true for T helper cell responses. This concept is particularly relevant to the development of vaccines. against viruses such as human immunodeficiency virus and hepatitis C virus, in which myriad viral variants are present throughout the human population. We have compared the effects of priming the immune system with a single peptide epitope or with a cocktail of related peptides based on the epitope. Our data demonstrate that immunization with multiple peptide variants expands a more broadly reactive and durable T helper cell response than does immunization with a single peptide. This vaccine strategy may circumvent original antigenic sin. (C) 2001 Academic Press.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 26 条
[1]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[2]   Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].
Baba, TW ;
Liska, V ;
Hofmann-Lehmann, R ;
Vlasak, J ;
Xu, WD ;
Ayehunie, S ;
Cavacini, LA ;
Posner, MR ;
Katinger, H ;
Stiegler, G ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Lu, YC ;
Wright, JE ;
Chou, TC ;
Ruprecht, RM .
NATURE MEDICINE, 2000, 6 (02) :200-206
[3]   Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].
Barouch, DH ;
Santra, S ;
Schmitz, JE ;
Kuroda, MJ ;
Fu, TM ;
Wagner, W ;
Bilska, M ;
Craiu, A ;
Zheng, XX ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Nickerson, CE ;
Trigona, WL ;
Punt, K ;
Freed, DC ;
Guan, LM ;
Dubey, S ;
Casimiro, D ;
Simon, A ;
Davies, ME ;
Chastain, M ;
Strom, TB ;
Gelman, RS ;
Montefiori, DC ;
Lewis, MG ;
Emini, EA ;
Shiver, JW ;
Letvin, NL .
SCIENCE, 2000, 290 (5491) :486-492
[4]   Immunogenicity of a vaccine preparation representing the variable regions of the HIV type 1 envelope glycoprotein [J].
Carlos, MP ;
Anderson, DE ;
Gardner, MB ;
Torres, JV .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (02) :153-161
[5]   DISQUISITIONS ON ORIGINAL ANTIGENIC SIN .2. PROOF IN LOWER CREATURES [J].
DESTGROTH, SF ;
WEBSTER, RG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1966, 124 (03) :347-+
[6]   DISQUISITIONS ON ORIGINAL ANTIGENIC SIN .I. EVIDENCE IN MAN [J].
DESTGROTH, SF ;
WEBSTER, RG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1966, 124 (03) :331-+
[7]   Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1 [J].
Gauduin, MC ;
Parren, PWHI ;
Weir, R ;
Barbas, CF ;
Burton, DR ;
Koup, RA .
NATURE MEDICINE, 1997, 3 (12) :1389-1393
[8]   Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma [J].
Igarashi, T ;
Brown, C ;
Azadegan, A ;
Haigwood, N ;
Dimitrov, D ;
Martin, MA ;
Shibata, R .
NATURE MEDICINE, 1999, 5 (02) :211-216
[9]   Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes [J].
Klenerman, P ;
Zinkernagel, RM .
NATURE, 1998, 394 (6692) :482-485
[10]   Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment [J].
Lifson, JD ;
Rossio, JL ;
Arnaout, R ;
Li, L ;
Parks, TL ;
Schneider, DK ;
Kiser, RF ;
Coalter, VJ ;
Walsh, G ;
Imming, RJ ;
Fisher, B ;
Flynn, BM ;
Bischofberger, N ;
Piatak, M ;
Hirsch, VM ;
Nowak, MA ;
Wodarz, D .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2584-2593